India reported more than 160,000 Covid infections on Sunday, the highest globally, as it overtook Brazil to become the second-worst hit country in the pandemic.
Horizons Regional Council adopts recommendations on intensive farming
13 Apr, 2021 05:00 PM
4 minutes to read
Nutrient leaching from dairy farms and commercial vegetable growing gets updated rules in Horizons One Plan. Photo / File
Nutrient leaching from dairy farms and commercial vegetable growing gets updated rules in Horizons One Plan. Photo / File
Laurel Stowell is a reporter for the Whanganui Chroniclelaurel.stowell@whanganuichronicle.co.nzWhangaChron
Horizons Regional Council has adopted recommendations that will allow some intensive farming operations to apply for resource consent - after a gap of three years. At its strategy and policy meeting on Tuesday, councillors adopted the recommendations a three-member panel has made on rules to limit nutrient leaching in target catchments in Tararua, Horowhenua and coastal Rangitīkei.
(1)
DUBLIN, April 12, 2021 /PRNewswire/ Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy.
The GI Genius module FDA approval marks a pivotal milestone for Cosmo after more than 10 years of research and investments focused to generate disruptive innovations in the field of colon s disease and optimization of the colonoscopy procedure. The development of GI Genius intelligent endoscopy module has been possible thanks to the leadership position of Cosmo, its unique proprietary library of high-definition loss-less videos of colonoscopies and its proprietary software and algorithms. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer. Medt